According to reports from The Financial Express, Thirumalai Chemicals shares closed at ₹170.05 on August 5, 2026, representing a decline of ₹8.63 from the previous close of ₹186.05. The stock experienced intraday highs of ₹180.60 and lows of ₹168.30, with trading volume reaching 1,04,010 shares. The company's market capitalization stands at ₹2,049.40 crore as of August 5, 2026.
As reported by The Financial Express, Thirumalai Chemicals has significantly underperformed its peers over the past year, declining 41.06% compared to Pidilite Industries' 9.62% gain. The company's three-month performance shows a 22.73% decline, while six-month returns stand at -13.38%. From a five-year perspective, the stock has underperformed relative to Pidilite Industries' 7.86% returns and Apar Industries' 87.83% gains, according to the latest data from Dion Global.
According to technical analysis from Dion Global, the stock's 5-day SMA stands at ₹173.47 with EMA at ₹178.61, while the 10-day SMA is positioned at ₹170.53 with EMA at ₹174.61. The 20-day SMA is located at ₹168.47 with EMA at ₹172.44, and the 50-day SMA is positioned at ₹175.39 with EMA at ₹176.16. The 100-day SMA is at ₹182.85 with EMA at ₹185.43, and the 200-day SMA is at ₹206.79 with EMA at ₹204.81.
As reported by The Financial Express, the latest quarter showed significant changes in shareholding patterns for Thirumalai Chemicals. The DII stake increased to 10.07%, while FII holding fell to 1.46%, and public shareholding moved up to 51.34% compared to the previous quarter. This shift in investor sentiment across categories reflects changing market dynamics for the specialty chemicals company, according to the latest data from Dion Global.
According to The Financial Express, the company announced its Q1 FY2026 financial results on August 4, 2026, along with compliance statements under SEBI regulations. The company also received a show cause notice under Section 73 of the CGST Act on July 31, 2026. Thirumalai Chemicals operates in the chemicals sector and is classified as a smallcap stock on BSE, with total operating revenue of ₹1,359.73 crore and equity capital of ₹12.06 crore for the year ended March 31, 2026.
